美吾華

-0.10 (-0.48%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

20.8068成交張數13.77本益比1.26股價淨值比5.87%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	35	22	37.0%	2.06	16.50	9.5%	6.0%	0.4	0.4
2026Q1	33	22	32.9%	2.75	16.72	8.5%	5.7%	0.4	0.4
2025Q4	32	22	33.2%	2.79	16.27	8.5%	5.6%	1.1	1.1
2025Q3	31	21	32.9%	2.92	15.68	8.4%	5.6%	0.7	0.6
2025Q2	32	20	36.9%	2.25	15.30	8.6%	5.5%	0.5	0.5
2025Q1	32	22	32.8%	2.89	16.35	7.9%	5.4%	0.0	-0.0
2024Q4	32	21	33.7%	2.64	15.85	8.4%	5.8%	0.7	-0.2
2024Q3	31	21	32.8%	2.41	15.58	8.5%	5.9%	0.2	-0.0
2024Q2	31	20	35.6%	2.14	15.16	8.7%	5.9%	0.8	-0.1
2024Q1	30	21	30.6%	2.76	15.91	8.4%	6.1%	0.4	-0.2
2023Q4	28	20	28.1%	3.07	15.33	8.4%	6.3%	0.7	0.2
2023Q3	28	20	27.4%	3.00	15.15	8.2%	6.3%	0.6	-0.6
2023Q2	27	20	28.3%	2.39	14.83	8.6%	6.5%	0.8	0.3
2023Q1	27	21	23.2%	3.04	15.46	8.0%	6.2%	0.4	-0.0
2022Q4	25	20	21.1%	3.36	15.02	8.1%	6.2%	0.5	-0.5
2022Q3	24	20	18.0%	3.46	14.76	8.1%	6.4%	0.2	0.2
2022Q2	24	19	19.5%	2.18	14.44	8.0%	6.3%	0.6	-0.1
2022Q1	27	21	23.7%	2.12	15.46	8.4%	6.4%	0.2	-0.4
2021Q4	27	20	25.5%	3.62	15.09	8.5%	6.4%	1.0	1.0
2021Q3	26	20	25.0%	3.83	14.71	8.6%	6.5%	0.4	0.4
2021Q2	27	20	23.7%	4.14	15.39	8.7%	6.5%	0.5	0.4
2021Q1	26	20	23.7%	4.02	14.77	9.7%	7.3%	0.8	0.8
2020Q4	25	19	24.2%	4.24	14.11	9.4%	6.6%	0.5	0.5
2020Q3	24	18	24.6%	4.11	13.82	8.7%	6.0%	1.1	1.1
2020Q2	24	18	26.5%	3.57	13.40	7.6%	5.1%	1.4	0.2
2020Q1	23	18	24.2%	4.80	13.34	5.4%	3.8%	-0.7	-0.7
2019Q4	27	18	35.8%	2.38	13.22	5.8%	3.7%	1.2	1.1
2019Q3	27	17	35.1%	2.42	13.12	5.1%	3.3%	0.3	0.3
2019Q2	28	17	37.6%	2.18	12.99	5.4%	3.3%	1.0	1.0
2019Q1	27	18	34.0%	2.49	13.30	5.0%	3.2%	-0.3	-0.3
2018Q4	27	17	35.7%	2.29	12.94	4.4%	2.9%	1.0	1.0
2018Q3	27	17	36.4%	2.19	13.10	5.4%	3.5%	0.0	-0.0
2018Q2	28	17	39.3%	1.95	13.01	5.7%	3.6%	0.7	0.7
2018Q1	28	18	36.5%	2.21	13.53	5.2%	3.4%	0.6	0.5
2017Q4	27	18	33.7%	2.10	13.22	4.9%	3.3%	0.7	0.6
2017Q3	27	17	34.3%	2.09	13.15	6.1%	4.1%	1.5	1.4
2017Q2	26	17	35.9%	1.98	12.75	6.2%	4.0%	-0.2	-0.2
2017Q1	26	17	32.2%	2.21	13.14	5.6%	3.8%	0.3	0.3
2016Q4	26	17	33.6%	2.09	12.99	–	–	0.2	0.2
2016Q3	25	17	32.7%	2.10	12.78	–	–	0.3	0.2